| abstract |
This invention relates to compounds of Formula (I) wherein one of R, R and R is (Formula II), and X, X, Y to Y, R to R and m and n are as defined in the description, and to all enantiomers and pharmaceutically acceptable salts and/or esters thereof The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are modulated by PPARĪ“ and/or PPARĪ± agonists. |